Efficacy of Sulfadoxine-Pyrimethamine for Treating Malaria in Gabonese Children

NCT00453856 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

139

Enrollment

UNKNOWN

Sponsor class

Stopped The study was terminated because of Early Treatment Failure in child.The justification for this decision are concerns about safety of children.

Conditions

Malaria

Interventions

DRUG: Sulfadoxine Pyrimethamine

Sponsor

Albert Schweitzer Hospital, Netherlands

Collaborators

[object Object]
[object Object]